Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 83

1.

EVALUATION OF SURGICAL FACTORS AFFECTING VITREOUS HEMORRHAGE FOLLOWING PORT DELIVERY SYSTEM WITH RANIBIZUMAB IMPLANT INSERTION IN A MINIPIG MODEL.

Bantseev V, Schuetz C, Booler HS, Horvath J, Hovaten K, Erickson S, Bentley E, Nork TM, Freeman WR, Stewart JM, Barteselli G.

Retina. 2019 Aug 19. doi: 10.1097/IAE.0000000000002614. [Epub ahead of print]

PMID:
31436674
2.

Determination of a No Observable Effect Level for Endotoxin Following a Single Intravitreal Administration to Cynomolgus Monkeys.

Bantseev V, Miller PE, Nork TM, Rasmussen CA, McKenzie A, Christian BJ, Booler H, Thackaberry EA.

J Ocul Pharmacol Ther. 2019 May;35(4):245-253. doi: 10.1089/jop.2018.0149. Epub 2019 Apr 9.

PMID:
30964386
3.

Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.

Yu JJ, Agrón E, Clemons TE, Domalpally A, van Asten F, Keenan TD, Cukras C, Chew EY; Age-Related Eye Disease Study 2 Research Group.

Ophthalmology. 2019 Feb;126(2):261-273. doi: 10.1016/j.ophtha.2018.08.017. Epub 2018 Aug 22.

PMID:
30142373
4.

Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.

Keenan TD, Agrón E, Domalpally A, Clemons TE, van Asten F, Wong WT, Danis RG, Sadda S, Rosenfeld PJ, Klein ML, Ratnapriya R, Swaroop A, Ferris FL 3rd, Chew EY; AREDS2 Research Group.

Ophthalmology. 2018 Dec;125(12):1913-1928. doi: 10.1016/j.ophtha.2018.05.028. Epub 2018 Jul 27.

5.

Biomechanical, ultrastructural, and electrophysiological characterization of the non-human primate experimental glaucoma model.

Raghunathan V, Eaton JS, Christian BJ, Morgan JT, Ver Hoeve JN, Yang CC, Gong H, Rasmussen CA, Miller PE, Russell P, Nork TM, Murphy CJ.

Sci Rep. 2017 Oct 30;7(1):14329. doi: 10.1038/s41598-017-14720-2.

6.

Effects of Vitrectomy and Lensectomy on Older Rhesus Macaques: Oxygen Distribution, Antioxidant Status, and Aqueous Humor Dynamics.

Siegfried CJ, Shui YB, Tian B, Nork TM, Heatley GA, Kaufman PL.

Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4003-4014. doi: 10.1167/iovs.17-21890.

7.

TWO CASES OF ACUTE RETINAL NECROSIS DUE TO VARICELLA ZOSTER DESPITE PRIOR SHINGLES VACCINATION.

Weinlander EJ, Wang AL, Jaru-Ampornpan P, Altaweel MM, Nork TM.

Retin Cases Brief Rep. 2019 Summer;13(3):241-243. doi: 10.1097/ICB.0000000000000567.

PMID:
28291069
8.

Microglia in the primate macula: specializations in microglial distribution and morphology with retinal position and with aging.

Singaravelu J, Zhao L, Fariss RN, Nork TM, Wong WT.

Brain Struct Funct. 2017 Aug;222(6):2759-2771. doi: 10.1007/s00429-017-1370-x. Epub 2017 Feb 17.

9.

Single ocular injection of a sustained-release anti-VEGF delivers 6months pharmacokinetics and efficacy in a primate laser CNV model.

Adamson P, Wilde T, Dobrzynski E, Sychterz C, Polsky R, Kurali E, Haworth R, Tang CM, Korczynska J, Cook F, Papanicolaou I, Tsikna L, Roberts C, Hughes-Thomas Z, Walford J, Gibson D, Warrack J, Smal J, Verrijk R, Miller PE, Nork TM, Prusakiewicz J, Streit T, Sorden S, Struble C, Christian B, Catchpole IR.

J Control Release. 2016 Dec 28;244(Pt A):1-13. doi: 10.1016/j.jconrel.2016.10.026. Epub 2016 Nov 1.

10.

Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia.

Ye GJ, Budzynski E, Sonnentag P, Nork TM, Miller PE, Sharma AK, Ver Hoeve JN, Smith LM, Arndt T, Calcedo R, Gaskin C, Robinson PM, Knop DR, Hauswirth WW, Chulay JD.

Hum Gene Ther Clin Dev. 2016 Mar;27(1):37-48. doi: 10.1089/humc.2015.164.

11.

Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia.

Ye GJ, Budzynski E, Sonnentag P, Nork TM, Miller PE, McPherson L, Ver Hoeve JN, Smith LM, Arndt T, Mandapati S, Robinson PM, Calcedo R, Knop DR, Hauswirth WW, Chulay JD.

Hum Gene Ther Clin Dev. 2016 Mar;27(1):27-36. doi: 10.1089/humc.2015.163.

12.

Toluene inhalation exposure for 13 weeks causes persistent changes in electroretinograms of Long-Evans rats.

Boyes WK, Bercegeay M, Degn L, Beasley TE, Evansky PA, Mwanza JC, Geller AM, Pinckney C, Nork TM, Bushnell PJ.

Neurotoxicology. 2016 Mar;53:257-270. doi: 10.1016/j.neuro.2016.02.008. Epub 2016 Feb 17.

13.

Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).

Daniel E, Shaffer J, Ying GS, Grunwald JE, Martin DF, Jaffe GJ, Maguire MG; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group.

Ophthalmology. 2016 Mar;123(3):609-16. doi: 10.1016/j.ophtha.2015.10.034. Epub 2015 Dec 8.

14.

Cone-Specific Promoters for Gene Therapy of Achromatopsia and Other Retinal Diseases.

Ye GJ, Budzynski E, Sonnentag P, Nork TM, Sheibani N, Gurel Z, Boye SL, Peterson JJ, Boye SE, Hauswirth WW, Chulay JD.

Hum Gene Ther. 2016 Jan;27(1):72-82. doi: 10.1089/hum.2015.130.

15.

Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.

Aref AA, Scott IU, Oden NL, Ip MS, Blodi BA, VanVeldhuisen PC; SCORE Study Investigator Group.

JAMA Ophthalmol. 2015 Sep;133(9):1022-9. doi: 10.1001/jamaophthalmol.2015.1823.

16.

Regional choroidal blood flow and multifocal electroretinography in experimental glaucoma in rhesus macaques.

Nork TM, Kim CB, Munsey KM, Dashek RJ, Hoeve JN.

Invest Ophthalmol Vis Sci. 2014 Nov 4;55(12):7786-98. doi: 10.1167/iovs.14-14527.

17.

Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).

Altaweel MM, Daniel E, Martin DF, Mittra RA, Grunwald JE, Lai MM, Melamud A, Morse LS, Huang J, Ferris FL 3rd, Fine SL, Maguire MG; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group; Comparison of Age-related Macular Degeneration Treatments Trials CATT Research Group.

Ophthalmology. 2015 Feb;122(2):391-398.e5. doi: 10.1016/j.ophtha.2014.08.020. Epub 2014 Oct 11.

18.

Response to aflibercept in patients with persistent exudation despite prior treatment with bevacizumab or ranibizumab for age-related macular degeneration.

Eadie JA, Gottlieb JL, Ip MS, Blodi BA, Danis RP, Chandra SR, Nork TM, Altaweel MM, Stern-Hogan BS.

Ophthalmic Surg Lasers Imaging Retina. 2014 Sep-Oct;45(5):394-7.

PMID:
25230402
19.

Quantifying optic nerve axons in a cat glaucoma model by a semi-automated targeted counting method.

Teixeira LB, Buhr KA, Bowie O, Duke FD, Nork TM, Dubielzig RR, McLellan GJ.

Mol Vis. 2014 Mar 28;20:376-85. eCollection 2014.

20.

Implications of retinal effects observed in chronic toxicity studies on the clinical development of a CNS-active drug candidate.

Eichenbaum G, Zhou J, Kelley MF, Roosen W, Costa-Giomi P, Louden C, Di Prospero NA, Pandina G, Singh JB, Ford L, Moyer JA, Nork TM, Ver Hoeve JN, Aguirre GD.

Regul Toxicol Pharmacol. 2014 Jul;69(2):187-200. doi: 10.1016/j.yrtph.2014.03.005. Epub 2014 Mar 26.

PMID:
24680767

Supplemental Content

Loading ...
Support Center